TAL seeks full control by buying Challenger stock

Published on 10/25/2026 at 00:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

TAL Daiichi Life seeks the remaining stake in an October 19, 2026 proposal. Challenger stock now depends on due diligence, approvals and board review.

Offer and operating figures

TAL Daiichi Life proposed to acquire Challenger's remaining stake on October 19, 2026.
First-quarter sales reached AUD 4.4 billion, up 52 percent year over year.
Challenger's market capitalization was AUD 8.1 billion as of October 23, 2026.

Challenger, AU000000CGF5, Illustration mit AI erstellt.

Challenger (ISIN AU000000CGF5) is reviewing a non-binding offer from TAL Daiichi Life Australia for the remaining 79.5 percent of its shares. Reuters reported the proposal on October 19, 2026, saying it valued Challenger at AUD 7.94 billion and offered AUD 11.80 per share. The board is considering the proposal, which remains subject to due diligence, regulatory approvals and a binding agreement.

Three events set the timeline

On October 2, 2026, Challenger completed a AUD 150.0 million on-market buyback and received approval for a new AUD 300.0 million program, according to MarketScreener. On October 19, 2026, a first-quarter update showed total sales of AUD 4.4 billion, up 52 percent year over year, while assets under management rose 5 percent to AUD 31.9 billion, as Capital Brief reported. The same date brought the takeover proposal.

What does the offer mean?

The AUD 11.80 proposal sits against a one-month volume-weighted average price of AUD 10.03, a 17.7 percent premium cited in the offer coverage. TAL Daiichi Life would acquire the 79.5 percent it does not already own, taking its stake to 100 percent if the conditions are met. Challenger's first-quarter operating figures add a separate measure of business momentum, with fixed-term sales up 103 percent to AUD 2.2 billion.

Next date for Challenger

The next dated event identified by Zonebourse is February 11, 2027, for second-quarter fiscal 2027 results. The date matters because the takeover review and the operating update now frame the next earnings comparison.

Market value and transaction gap

Challenger's market capitalization was AUD 8.1 billion as of October 23, 2026, while its 52-week range was AUD 7.25 to AUD 11.94. The offer therefore gives investors a clearly defined transaction reference, but the proposal remains conditional and the board has not announced a binding deal. The further course of trading is shown by the continuously updated real-time quote of Challenger stock.